International Business Machines (IBM) 159.07 $IBM US

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
International Business Machines (IBM) 159.07 $IBM

US appeals court rejects apartheid cases against Ford, IBM
By LARRY NEUMEISTER - AP - Mon Jul 27, 5:03PM CDT
NEW YORK (AP) — Victims of apartheid in South Africa cannot sue IBM Corp. and Ford Motor Co. in New York because they cannot show that the companies' alleged offending behavior occurred in the United States, a federal appeals court said Monday.
F: 14.55 (+0.16), IBM: 159.07 (-0.68)

Is the U.S. Bull Market Starting to Lose Its Luster?
at The Street - Mon Jul 27, 2:04PM CDT
CNBC’s ‘Fast Money’ traders take a closer look at U.S. stocks, as the selloff in China weighs on the market.
BIIB: 309.43 (+9.40), PRGO: 193.60 (+7.10), XOM: 79.26 (-0.68), MYL: 56.37 (-9.57), BMY: 64.30 (-1.68), AGN: 326.98 (+18.77), ISRG: 544.15 (-1.93), SBUX: 56.98 (-0.31), HCA: 92.03 (-0.80), IBM: 159.07 (-0.68), GM: 31.05 (-0.01), TEVA: 72.00 (+10.15), SPLK: 70.60 (-3.31), REGN: 540.03 (-1.82), NVS: 101.54 (-0.26)

Hate Twitter? 5 Reasons to Own It Anyway
at The Street - Mon Jul 27, 12:30PM CDT
The growth and potential are just too good to pass up.
AMZN: 531.41 (+1.99), IBM: 159.07 (-0.68), FB: 94.17 (-2.78), GOOGL: 658.27 (+3.50), TWTR: 34.70 (-0.72)

Forget Semiconductor ETFs; Try Other Options in the Tech Space - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Jul 27, 12:00PM CDT
Look beyond the struggling semiconductor ETFs for other great options in the tech sector.
MU: 18.12 (-0.22), IGV: 100.14 (-1.70), IBM: 159.07 (-0.68), FDN: 71.37 (-0.89), SMH: 51.01 (-0.20), SOXX: 86.31 (-0.64), INTC: 28.35 (+0.29), PNQI: 76.17 (-1.47), XSD: 78.01 (-0.87)

IBM and 9 Other Companies Giving Warren Buffett a Headache in 2015 -- Including One Jim Cramer Is Selling
at The Street - Mon Jul 27, 11:36AM CDT
Some of Warren Buffett's 'wonderful companies' haven't been treating him so wonderfully lately.
SU: 25.08 (-0.28), NOV: 41.65 (-0.57), AXP: 74.92 (-0.98), IBM: 159.07 (-0.68), FOXA: 33.17 (-0.49), WMT: 71.38 (-0.20), GM: 31.05 (-0.01), BRK.B: 140.72 (-0.53), PCP: 187.33 (-1.35), BRK.A: 210,725.00 (-1,307.30), UPS: 95.12 (+0.37)

IBM Rolls Out African Skills Initiative
PR Newswire - Mon Jul 27, 11:27AM CDT
IBM (NYSE: IBM) today announced an investment of $60 million over three years to develop the next generation of technical talent in Africa. As part of the initiative, IBM is expanding the Africa Technical Academy and the company's Africa University Programme to over 20 African countries. IT professionals across the continent are set to benefit with advanced skills in analytics, cloud and big data technologies which are crucial to the next phase of Africa's economic and social development.
IBM: 159.07 (-0.68)

Global Operation Business Process as a Service (BPaaS) Market 2015-2020 - Market is expected to grow from $27.76 Billion in 2015 to $47.45 Billion in 2020
M2 - Mon Jul 27, 9:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/f7wsv2/operation) has announced the addition of the "Operation Business Process as a Service (BPaaS) Market by Process (Order Management as a Service (OMaaS), SCM, Business Process Analytics, Digital Asset Management), Deployment (Hosted, On-Premise) - Global Forecast to 2020" report to their offering. The operation BPaaS market is expected to grow from $27.76 Billion in 2015 to $47.45 Billion in 2020 In the coming years, the market is expected to witness high growth in the regions, including Asia-Pacific, Latin America, and the Middle East & Africa (MEA). The Global Operation BPaaS report has an exhaustive list of 103 tables and 108 figures. The global operation BPaaS is dominated by companies, such as Accenture, Cognizant, Capgemini, SAP, IBM, and Fujitsu. This market research report analyzes global adoption trends, future growth potentials, key drivers, restraints, opportunities, and best practices in this market. The report also analyzes market sizes and revenue forecasts across different regions as well as industry verticals. The global operation BPaaS market has been segmented based on process into digital asset management, order management, supply chain management, industry operations, business process analytics, and others. Based on deployment model, the market has been segmented into hosted and on premise. The market has also been segmented based on service into design and consulting, system integration, support and maintenance, and others. Based on end users, the market has been categorized into enterprise and small and medium business. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Operation BPaaS Market, By Vertical 6 Operation BPaaS Market, By Deployment Model 7 Operation BPaaS Market, By End User 8 Operation BPaaS Market, By Process 9 Operation BPaaS Market, By Service 10 Operation BPaaS Market, By Geography 11 Operation BPaaS Market: Competitive Landscape 12 Global Operation BPaaS, By Company - Accenture - CA Technologies - CSC (Computer Sciences Corporation) - Capgemini - Cisco - Cognizant - Fujitsu - Genpact - IBM - Infosys - Oracle - SAP - Tata Consultancy Services (TCS) - Wipro Ltd. For more information visit http://www.researchandmarkets.com/research/f7wsv2/operation
WIT: 12.13 (-0.13), CSC: 64.59 (-0.87), IBM: 159.07 (-0.68)

Box Stock Upgraded on Customers Adds, Security Focus
at Investor's Business Daily - Mon Jul 27, 9:02AM CDT
Online file storage company Box corporate customer additions, focus on security, and strategic partnerships foreshadow more revenue upside while rivals such as Google (GOOGL) and Microsoft (MSFT) lose momentum, says Pacific Crest Securities. Analyst...
BOX: 16.64 (+0.35), IBM: 159.07 (-0.68), GOOGL: 658.27 (+3.50), MSFT: 45.35 (-0.59)

The Zacks Analyst Blog Highlights: IBM, Verizon Communications, Apple, Microsoft and Caterpillar - Press Releases
Zacks Equity Research - Zacks Investment Research - Mon Jul 27, 8:30AM CDT
The Zacks Analyst Blog Highlights: IBM, Verizon Communications, Apple, Microsoft and Caterpillar
IBM: 159.07 (-0.68), CAT: 75.32 (-0.78), MSFT: 45.35 (-0.59), AAPL: 122.77 (-1.73), VZ: 45.83 (-0.21)

Freedom Scientific Offers Enterprise Accessibility Training
PR Newswire - Mon Jul 27, 7:30AM CDT
Freedom Scientific has announced a collaboration with IBM to offer training modules to enable organizations to manage accessibility compliance and to ensure its integration throughout the enterprise. Freedom Scientific is now a global enterprise accessibility training provider for IBM Accessibility training modules.
IBM: 159.07 (-0.68)

Zementis Announces Predictive Analytics Integrated with IBM z Systems for Insight-driven Business Processes
GlobeNewswire - Mon Jul 27, 7:13AM CDT
via PRWEB - Zementis, Inc. and IBM Corporation (NYSE: IBM) today announced a joint strategic initiative and corresponding technology solution, "Zementis for IBM z Systems", designed for companies seeking to optimize business decisions and formulate those decisions faster. The solution seeks to unlock the full potential of an organization's data assets by integrating predictive analytics capabilities directly into transactional data flows that drive business processes.
IBM: 159.07 (-0.68)

The iPad's Stumble Is Painful to Watch
Evan Niu, CFA, The Motley Fool - Motley Fool - Sun Jul 26, 12:00PM CDT
Split View dramatically enhances the productivity of the iPad Air 2. Image source: Apple I believe in Tim Cook. I believe in tablets as a viable form factor for computing. I believe  Apple makes the best tablet on the market. So, when Tim Cook...
IBM: 159.07 (-0.68), AAPL: 122.77 (-1.73)


Scary headlines don't deter investors
By BERNARD CONDON - AP - Sat Jul 25, 3:17PM CDT
NEW YORK (AP) — The U.S. economy is growing at a painfully slow pace. Greece still threatens the euro. Chinese stocks have just pulled out of a frightening free-fall. Big companies in the U.S. are struggling to boost profits.
IBM: 159.07 (-0.68)

IBM Expands Reach to African Entrepreneurs with Innovation Space @ iHub
PR Newswire - Sat Jul 25, 11:01AM CDT
At the Global Entrepreneurship Summit co-hosted by U.S. President Barack Obama in Kenya this weekend, IBM (NYSE: IBM) announced a new innovation and collaboration space at iHub - the heart of Nairobi's tech community.
IBM: 159.07 (-0.68)

Can Tableau Software (DATA) Surprise This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 24, 4:31PM CDT
Analytics and data visualization software company, Tableau Software, Inc. (DATA) is set to release second-quarter 2015 earnings on Jul 27.
IBM: 159.07 (-0.68), FB: 94.17 (-2.78), DATA: 125.00 (-2.44), ORCL: 38.51 (-0.49)

Semiconductor Stocks Are Finally Coming Back Down to Earth
at The Street - Fri Jul 24, 2:26PM CDT
After rallying this year on a frenzy of multibillion-dollar mergers, semiconductor stocks are getting a reality check.
SWKS: 93.49 (-4.22), BRCM: 50.79 (-0.74), ALTR: 48.92 (-0.19), LLTC: 40.27 (+0.06), INTC: 28.35 (+0.29), IBM: 159.07 (-0.68), XLNX: 40.06 (-0.18), TXN: 49.03 (unch), QCOM: 61.98 (+0.34), MSFT: 45.35 (-0.59), AAPL: 122.77 (-1.73), AVGO: 124.65 (-3.83), SNDK: 61.16 (-0.68), FSI: 1.09 (-0.01)

Dow 30 Stock Roundup: 3M, Apple, Verizon Beat Estimates, AmEx, Caterpillar, IBM Earnings Dip - Analyst Blog
Swarup Gupta - Zacks Investment Research - Fri Jul 24, 11:27AM CDT
The Dow suffered a particularly dismal week, weighed down by disappointing earnings and weak oil prices.
KO: 40.54 (+0.10), MMM: 148.71 (-0.62), GE: 25.95 (+0.20), AXP: 74.92 (-0.98), UTX: 98.87 (-0.44), BA: 141.03 (-3.03), V: 73.86 (-0.94), IBM: 159.07 (-0.68), MCD: 96.04 (-0.06), CAT: 75.32 (-0.78), MSFT: 45.35 (-0.59), VZ: 45.83 (-0.21), AAPL: 122.77 (-1.73), TRV: 105.59 (+0.32)

7 Incredible Apple Patents That Might Hint at the Next Big Thing
at The Street - Fri Jul 24, 11:09AM CDT
The race for innovation is always running in Silicon Valley, and a quick way to stay on top is by tracking a company's patents. Here are seven of Apple's latest.
GPRO: 61.27 (-0.90), IBM: 159.07 (-0.68), FB: 94.17 (-2.78), QCOM: 61.98 (+0.34), GOOGL: 658.27 (+3.50), MSFT: 45.35 (-0.59), HPQ: 30.25 (-0.56), GOOG: 627.26 (+3.70), AAPL: 122.77 (-1.73)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 5

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 3

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 3

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 8

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 6

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 4

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading

Top 5 Most Recently Viewed Articles

Solar Insure Launches Innovative 30-Year Battery Warranty

Updated Category News Views 464

Solar Insure Introduces a New Battery Warranty Solar Insure is making a significant stride in the renewable energy sector with the introduction of the SI-30 Battery Warranty. This new warranty, featuring an impressive 30-year protection plan, is designed to give homeowners and solar providers peace of mind regarding their energy storage solutions. As battery storage...

Continue Reading
Opendoor's Road Ahead: Analysis of Settlement and Strategies

Updated Category News Views 175

Understanding Opendoor's Recent Settlement Opendoor Technologies (NASDAQ: OPEN) recently found itself in the spotlight due to a $39 million settlement aimed at resolving a federal class action lawsuit. This lawsuit stemmed from allegations that Opendoor misrepresented the effectiveness of its home-pricing algorithms, claiming to have improved automation when, in reality,...

Continue Reading
Scandinavian Tobacco Group Expands Share Buy-Back Program

Updated Category News Views 78

Scandinavian Tobacco Group Enhances Shareholder Value Scandinavian Tobacco Group A/S has recently taken significant steps to bolster its capital structure through a well-planned share buy-back program. This initiative aims to enhance shareholder value and support the management of obligations related to the company’s employee share-based incentive programs. Overview of...

Continue Reading
Akebia's Strategic Shift in Kidney Disease Drug Development

Updated Category News Views 205

The Shift in Akebia Therapeutics' Approach Akebia Therapeutics Inc. (NASDAQ: AKBA) has made headlines recently as its stock experienced a decline in value. This downward trend coincided with important discussions held between the company and the U.S. Food and Drug Administration (FDA) regarding its pivotal trial design for vadadustat, intended to treat anemia in patients...

Continue Reading
Fall Fun and Creativity at Art Ave in the Golden Triangle

Updated Category News Views 237

Art Ave Launches Exciting Fall Activities In the bustling heart of downtown, a new wave of creativity is set to unfold. This fall, the Golden Triangle Business Improvement District (BID) is thrilled to present Art Ave, an exhilarating outdoor initiative designed to connect the White House and Dupont Circle through vibrant public art and enriched community engagement....

Continue Reading